Page last updated: 2024-08-18

framycetin and Myocardial Infarction

framycetin has been researched along with Myocardial Infarction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BEST, MM; DUNCAN, CH1
Bauer, B; Kloner, RA; Przyklenk, K; Simkhovich, BZ1
Markkanen, T; Salmi, HA; Sotaniemi, E1

Trials

1 trial(s) available for framycetin and Myocardial Infarction

ArticleYear
Effect of neomycin treatment on the vitamin B12 content of human serum and urine.
    Zeitschrift fur Vitamin-, Hormon- und Fermentforschung, 1965, Volume: 14, Issue:1

    Topics: Blood; Clinical Trials as Topic; Humans; Myocardial Infarction; Neomycin; Urine; Vitamin B 12

1965

Other Studies

3 other study(ies) available for framycetin and Myocardial Infarction

ArticleYear
EFFECTS OF CHOLESTEROL-LOWERING DRUGS ON SERUM TRIGLYCERIDES.
    JAMA, 1964, Jan-04, Volume: 187

    Topics: Androsterone; Angina Pectoris; Arteriosclerosis; Cholesterol; Diabetes Mellitus; Humans; Lipids; Myocardial Infarction; Neomycin; Sterols; Thyroxine; Triglycerides

1964
Preconditioning-induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart.
    Basic research in cardiology, 1999, Volume: 94, Issue:1

    Topics: Animals; Heart; Hemodynamics; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Neomycin; Protein Synthesis Inhibitors; Rabbits; Second Messenger Systems

1999
Lipid-lowering drugs.
    The Medical letter on drugs and therapeutics, 1975, Jun-06, Volume: 17, Issue:12

    Topics: Cellulose; Cholestyramine Resin; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipids; Myocardial Infarction; Neomycin; Nicotinic Acids

1975